( June 18, 2025, 12:59 PM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals ruled that a district court did not err in certifying a national third-party payer (TPP) class of entities that paid for the diabetes drug Actos, agreeing with the lower court that the predominance requirement for certification was satisfied....